Research ArticleOriginal Article
Blockade of CD300A enhances the ability of human NK cells to lyse hematologic malignancies
Shuangcheng Li, Tianci Wang, Xinghui Xiao, Xiaodong Zheng, Haoyu Sun, Rui Sun, Hongdi Ma, Zhigang Tian and Xiaohu Zheng
Cancer Biology & Medicine April 2024, 21 (4) 331-346; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0341
Shuangcheng Li
1Hefei National Research Center for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230027, China
2Institute of Immunology, University of Science and Technology of China, Hefei 230027, China
Tianci Wang
1Hefei National Research Center for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230027, China
2Institute of Immunology, University of Science and Technology of China, Hefei 230027, China
Xinghui Xiao
1Hefei National Research Center for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230027, China
2Institute of Immunology, University of Science and Technology of China, Hefei 230027, China
Xiaodong Zheng
1Hefei National Research Center for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230027, China
2Institute of Immunology, University of Science and Technology of China, Hefei 230027, China
Haoyu Sun
1Hefei National Research Center for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230027, China
2Institute of Immunology, University of Science and Technology of China, Hefei 230027, China
Rui Sun
1Hefei National Research Center for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230027, China
2Institute of Immunology, University of Science and Technology of China, Hefei 230027, China
Hongdi Ma
1Hefei National Research Center for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230027, China
2Institute of Immunology, University of Science and Technology of China, Hefei 230027, China
Zhigang Tian
1Hefei National Research Center for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230027, China
2Institute of Immunology, University of Science and Technology of China, Hefei 230027, China
3Hefei TG ImmunoPharma Corporation Limited, Hefei 230601, China
4Research Unit of NK Cell Study, Chinese Academy of Medical Sciences, Beijing 100864, China
5Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
Xiaohu Zheng
1Hefei National Research Center for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230027, China
2Institute of Immunology, University of Science and Technology of China, Hefei 230027, China
5Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
References
- 1.↵
- Maomao C,
- He L,
- Dianqin S,
- Siyi H,
- Xinxin Y,
- Fan Y, et al.
- 2.↵
- 3.↵
- 4.
- Gross ND,
- Miller DM,
- Khushalani NI,
- Divi V,
- Ruiz ES,
- Lipson EJ, et al.
- 5.
- 6.
- 7.
- Rohaan MW,
- Borch TH,
- van den Berg JH,
- Met O,
- Kessels R,
- Geukes Foppen MH, et al.
- 8.↵
- 9.↵
- Ansell SM,
- Lesokhin AM,
- Borrello I,
- Halwani A,
- Scott EC,
- Gutierrez M, et al.
- 10.↵
- 11.↵
- 12.↵
- 13.↵
- Salik B,
- Smyth MJ,
- Nakamura K.
- 14.↵
- Green BJ,
- Clark GJ,
- Hart DN.
- 15.↵
- 16.↵
- Nakahashi-Oda C,
- Tahara-Hanaoka S,
- Shoji M,
- Okoshi Y,
- Nakano-Yokomizo T,
- Ohkohchi N, et al.
- 17.↵
- 18.↵
- 19.
- 20.
- Xu Y,
- Tarquini F,
- Romero R,
- Kim CJ,
- Tarca AL,
- Bhatti G, et al.
- 21.
- Silva R,
- Moir S,
- Kardava L,
- Debell K,
- Simhadri VR,
- Ferrando-Martinez S, et al.
- 22.↵
- Cao Y,
- Ao T,
- Wang X,
- Wei W,
- Fan J,
- Tian X.
- 23.↵
- 24.↵
- 25.↵
- Simhadri VR,
- Andersen JF,
- Calvo E,
- Choi SC,
- Coligan JE,
- Borrego F.
- 26.↵
- 27.↵
- 28.↵
- 29.↵
- 30.↵
- 31.↵
- Sabato V,
- Boita M,
- Shubber S,
- Bridts CH,
- Shibuya A,
- De Clerck LS, et al.
- 32.↵
- Swerdlow SH,
- Campo E,
- Harris NL,
- Jaffe ES,
- Pileri SA,
- Stein H, et al., editors.
- 33.↵
- Taylor J,
- Xiao W,
- Abdel-Wahab O.
- 34.↵
- Schenk LK,
- Schulze U,
- Henke S,
- Weide T,
- Pavenstadt H.
- 35.↵
- Hanayama R,
- Tanaka M,
- Miwa K,
- Shinohara A,
- Iwamatsu A,
- Nagata S.
- 36.↵
- 37.↵
- Song H,
- Song J,
- Cheng M,
- Zheng M,
- Wang T,
- Tian S, et al.
- 38.↵
- 39.↵
- Xu Z,
- Huang X.
- 40.↵
- 41.↵
- Gabrilovich DI.
- 42.↵
In this issue
Blockade of CD300A enhances the ability of human NK cells to lyse hematologic malignancies
Shuangcheng Li, Tianci Wang, Xinghui Xiao, Xiaodong Zheng, Haoyu Sun, Rui Sun, Hongdi Ma, Zhigang Tian, Xiaohu Zheng
Cancer Biology & Medicine Apr 2024, 21 (4) 331-346; DOI: 10.20892/j.issn.2095-3941.2023.0341
Blockade of CD300A enhances the ability of human NK cells to lyse hematologic malignancies
Shuangcheng Li, Tianci Wang, Xinghui Xiao, Xiaodong Zheng, Haoyu Sun, Rui Sun, Hongdi Ma, Zhigang Tian, Xiaohu Zheng
Cancer Biology & Medicine Apr 2024, 21 (4) 331-346; DOI: 10.20892/j.issn.2095-3941.2023.0341
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.